Ali, M., Redwan, M., Noaman, H., Ibrahim, M. (2023). ENDOSCOPIC PLANTAR FASCIA RELEASE IN CASES OF CHRONIC RESISTANT PLANTAR FASCIOPATHY. Egyptian Journal of Orthopedic Research, 4(1), 1-9. doi: 10.21608/ejor.2023.314662
Mohammed Ali; Mohammed Redwan; Hassan Noaman; Moustafa Ibrahim. "ENDOSCOPIC PLANTAR FASCIA RELEASE IN CASES OF CHRONIC RESISTANT PLANTAR FASCIOPATHY". Egyptian Journal of Orthopedic Research, 4, 1, 2023, 1-9. doi: 10.21608/ejor.2023.314662
Ali, M., Redwan, M., Noaman, H., Ibrahim, M. (2023). 'ENDOSCOPIC PLANTAR FASCIA RELEASE IN CASES OF CHRONIC RESISTANT PLANTAR FASCIOPATHY', Egyptian Journal of Orthopedic Research, 4(1), pp. 1-9. doi: 10.21608/ejor.2023.314662
Ali, M., Redwan, M., Noaman, H., Ibrahim, M. ENDOSCOPIC PLANTAR FASCIA RELEASE IN CASES OF CHRONIC RESISTANT PLANTAR FASCIOPATHY. Egyptian Journal of Orthopedic Research, 2023; 4(1): 1-9. doi: 10.21608/ejor.2023.314662
ENDOSCOPIC PLANTAR FASCIA RELEASE IN CASES OF CHRONIC RESISTANT PLANTAR FASCIOPATHY
Orthopedic dept., Faculty of Medicine, Sohag Univ., Sohag, Egypt
Abstract
Purpose : The intention of this study was to evaluate the efficacy of endoscopic plantar fascia release in the therapy of resistive plantar fasciopathy. Material and Methods: 30 individuals with plantar fasciopathy who had been recalcitrant to at least two forms of conservative therapy for at least six months were selected to participate in a prospective research.. Most of our patients had already been clinically diagnosed. Results: At 6 months after operation, the average AOFAS total score was significantly increased from 35 (8-62) up to 85.5 (range, 71-100), (P < 0.001). The median VAS score was significantly dropped from 10 (interquartile range, 9.25-10) up to 0 (interquartile range, 0-2.75) (P < 0.0001). The percentage of patients who scored good or exceptional on the Roles and Maudsley scale had dramatically risen after 4 weeks, rising from 73% to 93% (28/30). There were no serious adverse events. Conclusion: Endoscopic plantar fascia release is an efficient medication for people with relentless resistant plantar fasciopathy.